Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
For the six months, sales was INR 170.41 million compared to INR 190.72 million a year ago. Revenue was INR 188.97 million compared to INR 283.85 million a year ago. Net loss was INR 202.72 million compared to INR 131.12 million a year ago. Basic loss per share from continuing operations was INR 9.42 compared to INR 6.68 a year ago. Diluted loss per share from continuing operations was INR 9.42 compared to INR 6.68 a year ago.